Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Tobacco Use Disorder 1Smoking Cessation 1Meningioma 1Lung Neoplasms 1

Interventions

pembrolizumab 1282Specimen Handling 927Carboplatin 836Magnetic Resonance Spectroscopy 834Cyclophosphamide 807Cisplatin 735Nivolumab 680Paclitaxel 635Radiotherapy 617Gemcitabine 580Biopsy 559Bevacizumab 485Dexamethasone 444fludarabine 410Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 361Fluorouracil 357atezolizumab 350durvalumab 340Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 319Blood Specimen Collection 317Standard of Care 311Pemetrexed 307Ipilimumab 303Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fertility × 1 year × Clear all
NCT04798664 2026-02-25

Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening

Abramson Cancer Center at Penn Medicine

Phase NA Completed
3,228 enrolled 41 charts
Thoracic

Lung Neoplasms, Tobacco Use Disorder, Smoking Cessation

NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Thomas Jefferson University

Phase 1 Suspended
24 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡